Prescription drug · ANDA
Hydrochlorothiazide NDC 72162-1357
Hydrochlorothiazide 50 mg/1 · Tablet · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72162-1357-1 | 72162135701 | 100 TABLET in 1 BOTTLE, PLASTIC (72162-1357-1)Marketed from Feb 5, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Hydrochlorothiazide
- Generic name (nonproprietary)
- hydrochlorothiazide
- Active ingredients
- Hydrochlorothiazide — 50 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040412
- Marketing start
- Listing expires
- Other FDA classes
- Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
- Identifiers
- Product ID 72162-1357_2f36dc8e-b15a-4945-b8d9-25c98f5ba66bSPL ID 2f36dc8e-b15a-4945-b8d9-25c98f5ba66bSPL set ID 78d65a02-c78e-4f98-b756-3cb5ee78f252RxCUI 197770UNII 0J48LPH2TH
- Pharmacologic class
- Thiazide Diuretic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472162135701followed by a unit qualifier and the quantityPackage 72162-1357-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide tablets have also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension. Use in Pregnancy Routine use of diuretics during normal pregnancy is inappropriate and exposes m…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 040412
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Hydrochlorothiazide | Hydrochlorothiazide 50 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1451 |
| Hydrochlorothiazide | Hydrochlorothiazide 25 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1481 |
| Hydrochlorothiazide | Hydrochlorothiazide 50 mg/1 | TabletOral | Bryant Ranch Prepack | 63629-8992 |
| Hydrochlorothiazide | Hydrochlorothiazide 25 mg/1 | TabletOral | American Health Packaging | 60687-593 |
| Hydrochlorothiazide | Hydrochlorothiazide 50 mg/1 | TabletOral | Bryant Ranch Prepack | 63629-1220 |
| Hydrochlorothiazide | Hydrochlorothiazide 25 mg/1 | TabletOral | Bryant Ranch Prepack | 63629-1218 |
| Hydrochlorothiazide | Hydrochlorothiazide 25 mg/1 | TabletOral | Solco Healthcare U.S., LLC | 43547-397 |
| Hydrochlorothiazide | Hydrochlorothiazide 50 mg/1 | TabletOral | Solco Healthcare U.S., LLC | 43547-398 |